DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands

Biophysical Journal

Volumn 78, Issue 4, 2000, Pages 2008-2021

  Malina, Jaroslav ^a   Hofr, Ctirad ^a   Maresca, Luciana ^b   Natile, Giovanni ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN DERIVATIVE; DNA; RNA POLYMERASE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOPHYSICS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIFFERENTIAL PULSE POLAROGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DNA ADDUCT; DNA BINDING; DNA CONFORMATION; DNA CROSS LINKING; DNA TRANSCRIPTION; DRUG DNA INTERACTION; ENANTIOMER; HYDROGEN BOND; PHYSICAL CHEMISTRY; THERMODYNAMICS;

EID: 0034034773     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(00)76748-8     Document Type: Article

References (72)

1. Ano, S. O., Z. Kuklenyik, and L. G. Marzilli. 1999. Structure and dynamics of Pt anticancer drug adduct from nucleotides to oligonucleotides as revealed by NMR methods. In Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. B. Lippert, editor. VHCA. WELEY-VCH. Zürich, Weinheim. 247-291.
2. Bailly, C., D. Gentle, F. Hamy, M. Purcell, and M. J. Waring. 1994. Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin. Biochem. J. 300:165-173.
3. Bailly, C., and M. Waring. 1997. Diethylpyrocarbonate and osmium tetroxide as probes for drug-induced changes in DNA conformation in vitro. In Drug-DNA Interaction Protocols. K. R. Fox, editor. Humana Press Inc., Totowa, NJ. 51-79.
4. Bellon, S. F., J. H. Coleman, and S. J. Lippard. 1991. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). Biohemstry. 30:8026-8035.
5. +. Biophys. Chem. 35:179-188.
6. 1. Chem. Eur. J. 2:1283-1291.
7. Berners-Price, S. J., A. Corazza, Z., J. Guo, K. J. Barnham, P. J. Sadler, Y. Ohyama, M. Leng, and D. Locker. 1497. Structural transitions of a GG-platinated DNA duplex induced by pH, temperature and box A of high-mobility-group protein I. Eur. J. Biochem. 243:782-791.
8. Bloemink, M. J., and J. Reedijk. 1996. Cisplatin and derived anticancer drugs: Mechanism and current status of DNA binding. In Metal Ions in Biological Systems. A. Sigel, and H. Sigel, editors. Marcel Dekker, Inc., New York, Basel, Hong Kong. 641-686.
9. Boudný, V., O. Vrána, F. Gaucheron, V. Kleinwächter, M. Leng, and V. Brabec. 1992, Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes. Nucleic Acids Res. 20: 267-272.
10. Brabec, V., V. Boudný. and Z. Balcarová. 1994. Monofunctional adducts of platintmi(II) produce in DNA a sequence-dependenl local denaturation. Biochemistry: 32:1316-1322.
11. Brabec, V., and M. Leng. 1993. DNA interstrand cross-links of trans-dianiminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl. Acad. Sci. USA. 90:5345-5349.
12. Brabec, V., and E. Paleček. 1970. The influence of salts and pH on polarographic currents produced by denatured DNA. Biophysik. 6:290-300.
13. Brabec, V., and E. Paleček. 1976. Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. Biophys. Chem. 4:76-92.
14. Brabec, V., J. Reedijk, and M Leng. 1992. Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry. 31:12397-12402.
15. Brabec, V., M. Šíp, and M. Leng. 1993. DNA conformational distortion produced by site-specific interstrand cross-link of trans-diamminedichloroplatinum(H). Biochemistry, 32:11676-11681.
16. Coluccia, M., M. Correale, D. Giordano, M. A. Mariggio, Moscelli S., F. P. Fanizzi, G. Natile, and L. Maresca. 1986. Mutagenic activity of some platinum complexes with monodentate and bidentate amines. Inorg. Chim. Acta. 123:225-229.
17. Coluccia, M., F. P. Fanizzi, G. Giannini, D. Giordano, F. P. Intini, G. Lacidogna, F. Loseto, M. A. Mariggio, A. Nassi. and G. Natile. 1991. Synthesis, mutagenicity. binding to pBR 322 DNA and untitumor activity of platinum(II) complexes with ethamhutol. Anticancer Res. 11: 281-288.
18. Corda, Y., M. F. Anin, M. Leng, and D. Job. 1992. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinuni(II). Biochemistry. 31:1904-1908.
19. Corda, Y., C. Job, M. F. Anin, M. Leng, and D. Job. 1991. Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AC) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry. 30:222-230.
20. + in aqueous solution. A high field (500-300 MH/) nuclear magnetic resonance investigation. Nucleic Acids Res. 10:4715-4730.
21. Fanizzi, F. P., F. P. Intini, L. Maresca, G. Natile, R. Quaranata, M. Coluccia, L. Di Bari, D. Giordano, and M. A. Mariggió. 1987. Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate diamine ring Inorg. Chim. Acta. 137: 45-51.
22. Farrell, N., Y. Qu, L. Feng, and B. Van Houten. 1990. Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogs. Biochemistry. 29:9522-9531.
23. Fenton, R. R., W. J. Fasdale, H. M. Er, S. M. OMara, M. J. McKeage, P. J. Russell, and T. W. Hambley. 1997. Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, |(R)-and (S)-3-aminohexahydroazepine|dichloro-platinum(II). Crystal structure of the S enantiomer. J. Med. Chem. 40:1090-1098.
24. Gelasco, A., and S. J. Lippard. 1998. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry. 37:9230-9239.
25. Giannini, G., and G. Natile. 1991. Steric constraints inside the metal-coordination sphere as revealed by diastereotopic splitting of methylene protons. Inorg. Chem. 30:2853-2855.
26. Grabner, S., J. Plavec, N. Bukovec, D. Di Leo, R. Cini, and G. Natile. 1998. Synthesis and structural characterization of platinum(II)-acyclovir complexes. J. Chem. Soc. Dalton Trans. 1447-1451.
27. Herr, W. 1985. Diethyl pyrocarbonate: a chemical probe for secondary structure in negatively supercoiled DNA. Proc. Natl. Acad. Sci. USA. 82:8009-8013.
28. Huang, H. F., L. M. Zhu, B. R. Reid, G. P. Drobny, and P. B. Hopkins. 1995. Solution structure of a cisplatin-induced DNA interstrand cross-link. Science. 270:1842-1845.
29. Jennerwein, M. M., A. Eastman, and A. Khokhar. 1989. Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes. Chem.-Biol. Interactions. 70:39-49.
30. Johnson, N. P., J.-L. Butour, G. Villani, F. L. Wimmer, M. Defais, V. Pierson, and V. Brabec. 1989. Metal antitumor compounds: the mechanism of action of platinum complexes. Prog. Clin. Biochem. Med. 10:1-24.
31. Johnston, B. H., and A. Rich. 1985. Chemical probes of DNA conformation: detection of Z-DNA at nucleotide resolution. Cell. 42: 713-724.
32. Keck, M. V., and S. J. Lippard. 1992. Unwinding of supercoiled DNA by platinum ethidium and related complexes. J. Am. Chem. Soc. 114: 3386-3390.
33. Kidani, Y., K. Inagaki, M. Iigo, A. Hoshi, and K. Kuretani. 1978. Antitumor activity of 1,2-diamminocyclohexane-platinum complexes against Sarcoma 180 ascites form. J. Med. Chem. 21:1315-1318.
34. Kim, S. D., O. Vrána, V. Kleinwächter, K. Niki, and V. Brabec. 1990. Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA. Anal. Lett. 23:1505-1518.
35. Kline, T. P., L. G. Marzilli, D. Live, and G. Zon. 1989. Investigations of platinum amine induced distortions in single-and double-stranded oligodeoxyribonucleotides. J. Am. Chem. Soc: 111:7057-7067.
36. Koo, H. S., and D. M. Crothers. 1988. Calibration of DNA curvature and a unified description of sequence-directed bending. Proc. Natl. Acad. Sci. USA. 85:1763-1767.
37. Koo, H. S., J. Drak, J. A. Rice, and D. M. Crothers. 1990. Determination of the extent of DNA bending by an adenine-thymine tract. Biochemistry. 29:4227-4234.
38. Koo, H. S., H. M. Wu, and D. M. Crothers. 1986. DNA bending at adenine · thymine tracts. Nature. 320:501-506.
39. 2+ *: a clue to the adduct structure. Eur. J. Biochem. 205:895-906.
40. Lemaire, M. A., A. Schwartz, A. R. Rahmouni, and M. Leng. 1991. Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum(II) and DNA. Proc. Natl. Acad. Sci. USA. 88:1982-1985.
41. Leng, M. 1990. DNA bending induced by covalently bound drugs - gel electrophoresis and chemical probe studies. Biophys. Chem. 35: 155-163.
42. Malinge, J.-M., C. Perez, and M. Leng. 1995. Base sequence-independent distortions induced by interstrand cross-links in cis-diamminedichloroplatmum(II)-modified DNA. Nucleic Acids Res. 22:3834-3839.
43. Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560.
44. McCarthy, J. G., and A. Rich. 1991. Detection of an unusual distortion in A-tract DNA using KMnO4: effect of temperature and distamycin on altered conformation. Nucleic Acids Res. 19:3421-3429.
45. McCarthy, J. G., L. D. Williams, and A. Rich. 1990. Chemical reactivity of potassium permanganate and diethyl pyrocarbonate with B-DNA: specific reactivity with short A-tracts. Biochemistry. 29:6071-6081.
46. 1H NMR investigation of the effects on an oligodeoxyribonucleotide of intrastrand cross-linking by Pt anticancer drug. A large shift of C3′ accompanies an S to N conformational change. J. Am. Chem. Soc. 113:3021-3027.
47. Neumann, J. M., S. Tran-Dinh, J. P. Girault, J. C. Chottard, T. HuynhDinh, and J. Igolen. 1984. DNA fragment conformations. A 1-NMR conformational analysis of the d(G-G)-chelated platinum-oligonucleotide d(A-T-G-G)cisPt. Eur. J. Biochem. 141:465-472.
48. Nielsen, P. E. 1990. Chemical and photochemical probing of DNA complexes. J. Mol. Recognition. 3:1-24.
49. Noji, M., S. Motoyama, T. Tashiro, and Y. Kidani. 1983. Synthesis and antitumor activity of Pt(II) complexes containing 2,3-diaminopropanol isomers. Chem. Pharm. Bull. Tokyo. 31:1469-1473.
50. Noji, M., K. Okamato, and Y. Kidani. 1981. Relation of conformation to antitumor activity of platinum(II) complexes of 1,2-cyclohexanediamine and 2-(aminoethyl)cyclohexamine isomers against leukemia P388. J. Med. Chem. 24:508-515.
51. Nováková, O., O. Vrána, V. I. Kiseleva, and V. Brabec. 1995. DNA interactions of antitumor platinum(IV) complexes. Eur. J. Biochem. 228:616-624.
52. O'Dwyer, P. J., J. P. Stevenson, and S. W. Johnson. 1999. Clinical status of cisplatin, carboplatin, and other platinum-based antitumor drugs. In Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. B. Lippert, editor. VHCA, WILEY-VCH, Zürich, Weinheim. 31-72.
53. Ohndorf, U.-M., M. A. Rould, Q. He, C. O. Pabo, and S. J. Lippard. 1999. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature. 399:708-712.
54. Page, J. D., I. Husain, A. Sancar, and S. G. Chaney. 1990. Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality. Biochemistry. 29:1016-1024.
55. Pasini, A., and F. Zunino. 1987. New cisplatin analogs - on the way to better antitumor agents. Angew. Chem. Int. Ed. 26:615-624.
56. Pinto, A. L., and S. J. Lippard. 1985. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim. Biophys. Acta. 780:167-180.
57. Poklar, N., D. S. Pilch, S. J. Lippard, E. A. Redding, S. U. Dunham, and K. J. Breslauer. 1996. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc. Natl. Acad. Sci. USA. 93:7606-7611.
58. Reedijk, J. 1996. Improved understanding in platinum antitumour chemistry. Chem. Commun. 801-806.
59. Rhodes, D., and A. Klug. 1980. Helical periodicity of DNA determined by enzyme digestion. Nature. 286:573-578.
60. Rice, J. A., D. M. Crothers, A. L. Pinto, and S. J. Lippard. 1988. The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by 40° toward the major groove. Proc. Natl. Acad Sci. USA. 85:4158-4161.
61. Ross, S. A., and C. J. Burrows. 1996. Cytosine-specific chemical probing of DNA using bromide and monoperoxysulfate. Nucleic Acids Res. 24:5062-5063.
62. Schwartz, A., M. Sip, and M. Leng. 1990. Sodium cyanide: a chemical probe of the conformation of DNA modified by the antitumor drug cis-diamminedichloroplatinum(II). J. Am. Chem. Soc. 112:3673-3674.
63. Sherman, S. E., and S. J. Lippard. 1987. Structural aspects of platinum anticancer drug interactions with DNA. Chem. Rev. 87:1153-1181.
64. Sundquist, W. I., and S. J. Lippard. 1990. The coordination chemistry of platinum anticancer drugs and related compounds with DNA. Coord. Chem. Rev. 100:293-322.
65. Takahara, P. M., C. A. Frederick, and S. J. Lippard. 1996. Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J. Am. Chem. Soc. 118:12309-12321.
66. Ulanovsky, L., M. Bodner, E. N. Trifonov, and M. Choder. 1986. Curved DNA: design, synthesis, and circularization. Proc. Natl. Acad. Sci. USA. 83:862-866.
67. Van Boom, S. S. G. E., D. Z. Yang, J. Reedijk, G. A. Van der Marel, and A. H. J. Wang. 1996. Structural effect of intra-strand cisplatin-crosslink on palindromic DNA sequences. J. Biomol. Struct. Dyn. 13:989-998.
68. Vickery, K., A. M. Bonin, R. R. Fenton, S. O'Mara, P. J. Russell, L. K. Webster, and T. W. J. Hambley. 1993. Preparation, characterization. cytotoxicity, and mutagenicity of a pair of enantiomerie platinum(II) complexes with the potential to bind enantioselectively to DNA. J. Med. Chem. 36:3663-3668.
69. Vrána, O., V. Boudný, and V. Brabec. 1996. Superhelical torsion controls DNA interstrand cross-linking by antitumor cis-diamminedichloroplatinum(II). Nucleic Acids Res. 24:3918-3925.
70. Wang, J. C. 1979. Helical repeat of DNA in solution. Prof. Natl. Acad. Sci. USA. 76:200-203.
71. Žaludová, R., A. Žákovskǎ, J. Kašpárková, Z. Balcarová, V. Kleinwächter, O. Vrána, N. Farrell, and V. Brabec. 1997. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. Eur. J. Biochem. 246: 508-517.
72. Zamble, D. B., and S. J. Lippard. 1999. The response of cellular proteins to cisplatin-damaged DNA. In Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. B. Lippert, editor. VHCA, WILEY-VCH. Zürich, Weinheim. 73-110.